Akums Drugs & Pharmaceuticals Adverse Business Impact
Akums Drugs resumed 100% operations following a four-day disruption at Haridwar sites. The incident delayed ₹20 Crore in supply, but production loss recovery is expected.
- Value
- ₹20.00 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Akums Drugs resumed 100% operations following a four-day disruption at Haridwar sites. The incident delayed ₹20 Crore in supply, but production loss recovery is expected.
Akums Drugs resumed over 70% of Haridwar operations following industry-wide labor unrest. Normalcy is being restored with local authorities after disruptions triggered by minimum wage reviews.
Akums Drugs reported temporary operational disruptions at its Haridwar plants due to labor unrest. Management is actively negotiating with workers and local authorities to resolve the issue.